Home Applications 021090 Application 021090
Type NDA
Sponsor ASPEN GLOBAL INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CYCLESSA DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021090-001 CYCLESSA DESOGESTREL; ETHINYL ESTRADIOL 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG TABLET / ORAL-28 AB RLD, RS 2000-12-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021090-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021090-001 CYCLESSA 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG TABLET / ORAL-28 AB RLD, RS 2000-12-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021090-001 CYCLESSA 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG TABLET / ORAL-28 AB RLD, RS 2000-12-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021090-001 CYCLESSA 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG TABLET / ORAL-28 AB RLD, RS 2000-12-20 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021090-001 CYCLESSA 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG TABLET / ORAL-28 AB RLD, RS 2000-12-20 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 71028 SUPPL 2022-05-09 70931 SUPPL 2022-05-03 49370 SUPPL 2017-08-15 49316 SUPPL 2017-08-10 14376 SUPPL 2007-03-31 4314 SUPPL 2007-03-31 41949 ORIG 2004-05-06 26755 SUPPL 2004-02-25